Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Technology Industry News CoreWeave (NASDAQ: CRWV) accelerates past $5bn revenue as AI infrastructure demand hardens into long-term contracts CoreWeave, Inc.’s Q4 2025 results reveal explosive AI cloud growth, massive backlog expansion, and bold 2026 guidance. Discover what this means for investors. bySrinathMarch 1, 2026